Literature DB >> 19175703

Liposomes in dermatology today.

J de Leeuw1, H C de Vijlder, P Bjerring, H A M Neumann.   

Abstract

Liposomes are vesicles consisting of spherical phospholipid bi-layers with specific properties making them useful for topical application of drugs. Liposome research has expanded considerably over the last 30 years and nowadays, it is possible to construct a wide range of liposomes varying in size, phospholipids composition and surface characteristics to suit the specific application for which they are intended. In dermatology, the topical application of liposomes has proven to be of therapeutic value. Liposomes can be used as carriers for hydrophilic as well as lipophilic therapeutic agents because of their amphipathic character. They may improve stabilization of instable drugs by encapsulating them and serve as penetration enhancers facilitating the transport of compounds that otherwise cannot penetrate the skin. Liposomes help in reducing skin irritation by sustaining the release of drugs and by hydration of the epidermis. They also have the potential to target drugs into the pilosebaceous structures and hence they have an additional advantage for treatment of hair follicle-associated disorders. Clinical data indicate that 5-ALA encapsulated in liposomes improves the quality of Fluorescence Diagnosis by ALA-induced Porphyrins (FD) and optimizes the results of Photodynamic Therapy (PDT).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19175703     DOI: 10.1111/j.1468-3083.2009.03100.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  11 in total

1.  Topical enzyme-replacement therapy restores transglutaminase 1 activity and corrects architecture of transglutaminase-1-deficient skin grafts.

Authors:  Karin Aufenvenne; Fernando Larcher; Ingrid Hausser; Blanca Duarte; Vinzenz Oji; Heike Nikolenko; Marcela Del Rio; Margitta Dathe; Heiko Traupe
Journal:  Am J Hum Genet       Date:  2013-09-19       Impact factor: 11.025

Review 2.  Challenges and opportunities in dermal/transdermal delivery.

Authors:  Kalpana S Paudel; Mikolaj Milewski; Courtney L Swadley; Nicole K Brogden; Priyanka Ghosh; Audra L Stinchcomb
Journal:  Ther Deliv       Date:  2010-07

3.  Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.

Authors:  Sutapa Barua; Samir Mitragotri
Journal:  Nano Today       Date:  2014-04-01       Impact factor: 20.722

4.  Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids.

Authors:  Chun-Ming Huang; Chao-Hsuan Chen; Dissaya Pornpattananangkul; Li Zhang; Michael Chan; Ming-Fa Hsieh; Liangfang Zhang
Journal:  Biomaterials       Date:  2010-09-28       Impact factor: 12.479

Review 5.  Recent advances in the prevention and treatment of skin cancer using photodynamic therapy.

Authors:  Baozhong Zhao; Yu-Ying He
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

6.  Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials.

Authors:  P Severino; J F Fangueiro; S V Ferreira; R Basso; M V Chaud; M H A Santana; A Rosmaninho; E B Souto
Journal:  Clin Transl Oncol       Date:  2013-01-24       Impact factor: 3.405

Review 7.  Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.

Authors:  Pinaki Desai; Ram R Patlolla; Mandip Singh
Journal:  Mol Membr Biol       Date:  2010-10       Impact factor: 2.857

8.  Topical delivery of DNA oligonucleotide to induce p53 generation in the skin via thymidine dinucleotide (pTT)-encapsulated liposomal carrier.

Authors:  Yi-Ping Fang
Journal:  Int J Nanomedicine       Date:  2011-12-20

9.  Potentials of chitosan-based delivery systems in wound therapy: bioadhesion study.

Authors:  Julia Hurler; Nataša Skalko-Basnet
Journal:  J Funct Biomater       Date:  2012-01-06

10.  In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester.

Authors:  Beata Osiecka; Kamil Jurczyszyn; Krzysztof Symonowicz; Andrzej Bronowicz; Paweł Ostasiewicz; Elzbieta Czapińska; Katarzyna Hotowy; Małgorzata Krzystek-Korpacka; Elzbieta Gebarowska; Ilona Izykowska; Piotr Dziegiel; Grzegorz Terlecki; Piotr Ziółkowski
Journal:  Cell Mol Biol Lett       Date:  2010-09-17       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.